Ostem Implant, 3Q Sales 313.5 Billion KRW... Up 12.1% YoY

3Q Cumulative Sales and Operating Profit Both Reach All-Time Highs

Osstem Implant announced on the 28th that its consolidated sales for the third quarter of this year were tentatively recorded at 313.5195 billion KRW, an increase of 12.15% compared to the same period last year.

Ostem Implant Magok Central Research Center and Headquarters.
[Photo by Ostem Implant]

During the same period, operating profit rose 19.6% to 67.581 billion KRW, and net profit grew 18.2% to 49.752 billion KRW.

Osstem Implant explained that on a cumulative basis for the third quarter, both sales and operating profit reached record highs. The cumulative consolidated sales for the third quarter increased by 14.9% year-on-year to 895.2975 billion KRW, and cumulative operating profit grew 24.9% to 205.016 billion KRW.

By market, steady growth was seen both domestically and internationally. Domestic sales grew 11.2% compared to the previous year, reaching 300.9 billion KRW, while overseas sales increased 16.9% to 594.4 billion KRW.

The sales proportion showed remarkable growth in the global market, with the overseas share rising to 66.4%. Looking at overseas sales by region, the Americas region had the highest growth rate at 22.1%. Osstem Implant explained that this reflects the strong performance of the premium implant brand "HIOSSEN," produced by its U.S. subsidiary. HIOSSEN, launched for advanced markets such as North America and Europe, competes with global brands by emphasizing quality and clinical data. Strengthening sales to dental service organizations (DSOs) and focusing customized marketing tailored to the characteristics of the U.S. market were also factors behind the high growth.

Sales in the Asia region also increased by 17.4% year-on-year. The company explained that this was due to overcoming the newly implemented centralized purchasing (VBP) policy in China, the largest market share, and preparing for increased demand by establishing education and direct sales infrastructure in Japan, where digitalization is progressing, as well as in India and Vietnam, where the implant market is growing.

In the European region, double-digit sales growth was recorded due to increased corporate and brand awareness and the impact of direct sales infrastructure. Osstem Implant has been expanding its sales network in Europe by consecutively establishing new subsidiaries in France, Italy, the Netherlands, and Portugal during the first half of this year.

An Osstem Implant official said, "With the transition to endemic (periodic infectious disease outbreaks), we are significantly expanding clinical education and face-to-face sales targeting dentists worldwide, and greatly increasing domestic invitation training events, accelerating sales activation." He added, "We will strengthen our strong education system and enhance digital capabilities to surely achieve our goal of becoming the world's number one implant company by 2026."

This content was produced with the assistance of AI translation services.